Opioid Receptor Systems and Endogenous Opioids

The opioid system comprises a family of G-protein-coupled opioid receptors (mu, delta, and kappa) and the endogenous peptides that act on them, including the endorphins, enkephalins, and dynorphins. This system modulates pain, reward, and emotional responses, and it is the target of opioid analgesic drugs, which makes its pharmacology central to neuropsychopharmacology and to understanding opioid effects.

Definition

The opioid system is a neuromodulatory signalling system consisting of three classical G-protein-coupled opioid receptors (mu, delta, kappa) and a related non-classical receptor, together with endogenous opioid peptides (endorphins, enkephalins, dynorphins) derived from precursor proteins, that together modulate nociception, reward, and affect.

Scope

The topic covers the opioid receptor subtypes, their G-protein-coupled signalling, the endogenous opioid peptides and their precursors, and the system's roles in pain modulation and reward. It treats the opioid system as descriptive reference knowledge; it does not provide analgesic dosing, prescribing, or any individualised treatment guidance.

Core questions

• What are the opioid receptor subtypes and how do they signal?
• Which endogenous peptides activate the opioid receptors?
• How does the opioid system modulate pain and reward?
• Why is the opioid system a major pharmacological target?

Key concepts

• Mu, delta, and kappa opioid receptors
• Endogenous opioid peptides (endorphins, enkephalins, dynorphins)
• G-protein-coupled signalling and inhibition
• Pain modulation and descending control
• Reward and reinforcement
• Receptor agonists, partial agonists, and antagonists

Key theories

Endogenous opioid modulation of pain

The framework that endogenous opioid peptides acting on opioid receptors form an intrinsic system for dampening nociceptive signalling, which exogenous opioid drugs engage to produce analgesia.

Mechanisms

Opioid receptors are G-protein-coupled receptors that, when activated, inhibit adenylyl cyclase, open potassium channels, and close calcium channels, reducing neuronal excitability and transmitter release. Endogenous opioid peptides cleaved from precursor proteins act as the natural ligands, and the distinct roles of the mu, delta, and kappa receptors have been dissected through gene-knockout studies reviewed by Kieffer and Gaveriaux-Ruff (2002). Within nociceptive circuits the system modulates pain transmission, including through descending control, as described by Corder et al. (2018); the same receptors mediate reward-related and affective signalling. Drugs acting on these receptors range from full and partial agonists to antagonists, each engaging the system's signalling in characteristic ways.

Clinical relevance

Opioid receptors are the target of opioid analgesics and of agents used to reverse or block opioid effects, and the system's role in reward is central to understanding opioid use disorder. This entry is descriptive reference material on the system's biology and signalling; it does not provide dosing, prescribing, or treatment recommendations, which require qualified clinical judgement.

Evidence & guidelines

Opioid receptor classification follows IUPHAR consensus nomenclature; the cited Annual Review (Corder et al., 2018) and Progress in Neurobiology (Kieffer & Gaveriaux-Ruff, 2002) articles provide the authoritative descriptions of receptor function used here.

History

Specific opioid receptors were identified in the early 1970s, and the subsequent discovery of the enkephalins and other endogenous opioid peptides revealed an intrinsic signalling system that exogenous opioids exploit. Molecular cloning of the mu, delta, and kappa receptors and gene-knockout studies then clarified their individual roles, grounding the pharmacology of opioid drugs in a defined receptor system.

Seminal works

• corder-2018
• kieffer-2002

Frequently asked questions

What are the main opioid receptor types?

The three classical opioid receptors are the mu, delta, and kappa subtypes, all G-protein-coupled receptors; a related non-classical receptor is also recognised. Each subtype contributes differently to pain, reward, and affective signalling.

What are endogenous opioids?

Endogenous opioids are naturally occurring peptides, including the endorphins, enkephalins, and dynorphins, that the body produces to act on opioid receptors, forming an intrinsic system for modulating pain and reward.